The global AI in Life Science Analytics market , valued at USD 1,458.75 million in 2022 , is set to experience substantial growth, with a Compound Annual Growth Rate (CAGR) of 10.8% from 2023 to 2032. By the end of the forecast period, the market is projected to reach USD 4,067.97 million . This growth is fueled by the increasing adoption of artificial intelligence (AI) technologies across the life sciences sector, including healthcare, pharmaceuticals, and biotechnology, as well as the rising demand for data-driven decision-making in drug discovery, clinical trials, and patient care. Market Overview AI in life science analytics refers to the use of artificial intelligence technologies to analyze complex datasets in the life sciences field. These analytics can improve decision-making, streamline processes, and drive efficiency across the entire spectrum of life sciences, from drug development to patient care and disease management. By leveraging AI-driven algorithms, life sc...